vs

Side-by-side financial comparison of Campbell's Company (The) (CPB) and ResMed (RMD). Click either name above to swap in a different company.

Campbell's Company (The) is the larger business by last-quarter revenue ($2.7B vs $1.4B, roughly 1.9× ResMed). ResMed runs the higher net margin — 27.6% vs 7.2%, a 20.3% gap on every dollar of revenue. On growth, ResMed posted the faster year-over-year revenue change (11.0% vs -3.4%). Over the past eight quarters, ResMed's revenue compounded faster (7.9% CAGR vs 4.4%).

The Campbell's Company is an American company, most closely associated with its flagship canned soup products. The classic red-and-white can design used by many Campbell's branded products has become an American icon, and its use in pop art was typified by American artist Andy Warhol's series of Campbell's Soup Cans prints.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

CPB vs RMD — Head-to-Head

Bigger by revenue
CPB
CPB
1.9× larger
CPB
$2.7B
$1.4B
RMD
Growing faster (revenue YoY)
RMD
RMD
+14.4% gap
RMD
11.0%
-3.4%
CPB
Higher net margin
RMD
RMD
20.3% more per $
RMD
27.6%
7.2%
CPB
Faster 2-yr revenue CAGR
RMD
RMD
Annualised
RMD
7.9%
4.4%
CPB

Income Statement — Q1 FY2026 vs Q4 FY2026

Metric
CPB
CPB
RMD
RMD
Revenue
$2.7B
$1.4B
Net Profit
$194.0M
$392.6M
Gross Margin
29.6%
61.8%
Operating Margin
12.6%
34.6%
Net Margin
7.2%
27.6%
Revenue YoY
-3.4%
11.0%
Net Profit YoY
-11.0%
13.9%
EPS (diluted)
$0.65
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPB
CPB
RMD
RMD
Q2 26
$1.4B
Q4 25
$2.7B
$1.4B
Q3 25
$2.3B
$1.3B
Q2 25
$2.5B
$1.3B
Q1 25
$2.7B
$1.3B
Q4 24
$2.8B
$1.3B
Q3 24
$2.3B
$1.2B
Q2 24
$2.4B
$1.2B
Net Profit
CPB
CPB
RMD
RMD
Q2 26
$392.6M
Q4 25
$194.0M
$392.6M
Q3 25
$145.0M
$348.5M
Q2 25
$66.0M
$379.7M
Q1 25
$173.0M
$365.0M
Q4 24
$218.0M
$344.6M
Q3 24
$-3.0M
$311.4M
Q2 24
$133.0M
$292.2M
Gross Margin
CPB
CPB
RMD
RMD
Q2 26
61.8%
Q4 25
29.6%
61.8%
Q3 25
30.4%
61.5%
Q2 25
29.4%
60.8%
Q1 25
30.5%
59.3%
Q4 24
31.3%
58.6%
Q3 24
29.4%
58.6%
Q2 24
30.9%
58.5%
Operating Margin
CPB
CPB
RMD
RMD
Q2 26
34.6%
Q4 25
12.6%
34.6%
Q3 25
11.6%
33.4%
Q2 25
6.5%
33.7%
Q1 25
12.2%
33.0%
Q4 24
13.2%
32.5%
Q3 24
3.4%
31.6%
Q2 24
10.5%
31.2%
Net Margin
CPB
CPB
RMD
RMD
Q2 26
27.6%
Q4 25
7.2%
27.6%
Q3 25
6.2%
26.1%
Q2 25
2.7%
28.2%
Q1 25
6.4%
28.3%
Q4 24
7.9%
26.9%
Q3 24
-0.1%
25.4%
Q2 24
5.6%
23.9%
EPS (diluted)
CPB
CPB
RMD
RMD
Q2 26
$2.68
Q4 25
$0.65
$2.68
Q3 25
$0.49
$2.37
Q2 25
$0.22
$2.58
Q1 25
$0.58
$2.48
Q4 24
$0.72
$2.34
Q3 24
$-0.01
$2.11
Q2 24
$0.44
$1.97

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPB
CPB
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$168.0M
$1.4B
Total DebtLower is stronger
$6.1B
$663.8M
Stockholders' EquityBook value
$4.0B
$6.3B
Total Assets
$15.2B
$8.5B
Debt / EquityLower = less leverage
1.54×
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPB
CPB
RMD
RMD
Q2 26
$1.4B
Q4 25
$168.0M
$1.4B
Q3 25
$132.0M
$1.4B
Q2 25
$143.0M
$1.2B
Q1 25
$829.0M
$932.7M
Q4 24
$808.0M
$521.9M
Q3 24
$108.0M
$426.4M
Q2 24
$107.0M
$238.4M
Total Debt
CPB
CPB
RMD
RMD
Q2 26
$663.8M
Q4 25
$6.1B
$403.9M
Q3 25
$6.1B
$408.7M
Q2 25
$6.1B
$658.4M
Q1 25
$6.5B
$663.1M
Q4 24
$6.7B
$662.9M
Q3 24
$5.8B
$667.6M
Q2 24
$5.8B
$697.3M
Stockholders' Equity
CPB
CPB
RMD
RMD
Q2 26
$6.3B
Q4 25
$4.0B
$6.3B
Q3 25
$3.9B
$6.1B
Q2 25
$3.9B
$6.0B
Q1 25
$3.9B
$5.5B
Q4 24
$3.8B
$5.3B
Q3 24
$3.8B
$5.2B
Q2 24
$3.9B
$4.9B
Total Assets
CPB
CPB
RMD
RMD
Q2 26
$8.5B
Q4 25
$15.2B
$8.5B
Q3 25
$14.9B
$8.3B
Q2 25
$14.8B
$8.2B
Q1 25
$15.9B
$7.6B
Q4 24
$16.1B
$7.1B
Q3 24
$15.2B
$7.2B
Q2 24
$15.2B
$6.9B
Debt / Equity
CPB
CPB
RMD
RMD
Q2 26
0.11×
Q4 25
1.54×
0.06×
Q3 25
1.56×
0.07×
Q2 25
1.58×
0.11×
Q1 25
1.66×
0.12×
Q4 24
1.75×
0.13×
Q3 24
1.52×
0.13×
Q2 24
1.47×
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPB
CPB
RMD
RMD
Operating Cash FlowLast quarter
$224.0M
Free Cash FlowOCF − Capex
$97.0M
FCF MarginFCF / Revenue
3.6%
Capex IntensityCapex / Revenue
4.7%
Cash ConversionOCF / Net Profit
1.15×
TTM Free Cash FlowTrailing 4 quarters
$687.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPB
CPB
RMD
RMD
Q2 26
Q4 25
$224.0M
$339.7M
Q3 25
$259.0M
$457.3M
Q2 25
$135.0M
$538.8M
Q1 25
$512.0M
$578.7M
Q4 24
$225.0M
$308.6M
Q3 24
$288.0M
$325.5M
Q2 24
$213.0M
$440.1M
Free Cash Flow
CPB
CPB
RMD
RMD
Q2 26
Q4 25
$97.0M
$311.2M
Q3 25
$129.0M
$414.4M
Q2 25
$50.0M
$508.2M
Q1 25
$411.0M
$557.9M
Q4 24
$115.0M
$288.0M
Q3 24
$147.0M
$307.7M
Q2 24
$100.0M
$415.2M
FCF Margin
CPB
CPB
RMD
RMD
Q2 26
Q4 25
3.6%
21.9%
Q3 25
5.6%
31.0%
Q2 25
2.0%
37.7%
Q1 25
15.3%
43.2%
Q4 24
4.1%
22.5%
Q3 24
6.4%
25.1%
Q2 24
4.2%
33.9%
Capex Intensity
CPB
CPB
RMD
RMD
Q2 26
Q4 25
4.7%
2.0%
Q3 25
5.6%
3.2%
Q2 25
3.4%
2.3%
Q1 25
3.8%
1.6%
Q4 24
4.0%
1.6%
Q3 24
6.1%
1.5%
Q2 24
4.8%
2.0%
Cash Conversion
CPB
CPB
RMD
RMD
Q2 26
Q4 25
1.15×
0.87×
Q3 25
1.79×
1.31×
Q2 25
2.05×
1.42×
Q1 25
2.96×
1.59×
Q4 24
1.03×
0.90×
Q3 24
1.05×
Q2 24
1.60×
1.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CPB
CPB

Baked Snacks$995.0M37%
Snacks$914.0M34%
Simple Meals$580.0M22%
Beverages$168.0M6%

RMD
RMD

Segment breakdown not available.

Related Comparisons